nocodazole has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurosu, T; Miura, O; Nagao, T; Oshikawa, G; Wu, N | 1 |
1 other study(ies) available for nocodazole and imatinib mesylate
Article | Year |
---|---|
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.
Topics: Animals; Apoptosis; Benzamides; Cell Cycle; Cell Line; Etoposide; Flow Cytometry; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; Glycogen Synthase Kinase 3; Imatinib Mesylate; Immunoblotting; Immunoprecipitation; Janus Kinase 2; Mice; Nocodazole; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines | 2013 |